SL
Insider
Sung Lee
EVP, Chief Financial OfficerSung Lee (EVP, Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.2M of CYTK (38,730 sh × $82.30, as filed), executed Jun 24.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.6M
shares × price, as filed
Last traded
Jun 29
Filed Jun 29
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$266K3,134 sh × $85.00
Exec Jun 29
Filed Jun 29 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $3.2M
38,730 sh × $82.30
Exec Jun 24
Filed Jun 29 · 5:30 PM ET † CYTKSALE Cytokinetics, Incorporated View filing → $1.8M
23,906 sh × $76.87
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $307K
4,935 sh × $62.15
Exec Mar 17
Filed Mar 18 · 5:30 PM ET